600201 生物股份
已收盘 04-30 15:00:00
资讯
新帖
简况
生物股份获融资买入0.23亿元，近三日累计买入0.74亿元
金融界 · 05-01 08:24
生物股份获融资买入0.23亿元，近三日累计买入0.74亿元
东兴证券：给予生物股份买入评级
证券之星 · 04-30
东兴证券：给予生物股份买入评级
生物股份(600201)：经营质量持续提升 新品落地可期
东兴证券股份有... · 04-30
生物股份(600201)：经营质量持续提升 新品落地可期
生物股份04月30日主力资金流入1114万元 连续3日加仓
自选股智能写手 · 04-30
生物股份04月30日主力资金流入1114万元 连续3日加仓
生物股份(600201)2023年年报及2024年一季报点评：盈利能力提升，研发投入步入收获期
国海证券 · 04-30
生物股份(600201)2023年年报及2024年一季报点评：盈利能力提升，研发投入步入收获期
生物科技概念盘中拉升，泰林生物涨3.70%
自选股智能写手 · 04-30
生物科技概念盘中拉升，泰林生物涨3.70%
生物股份获国海证券买入评级，盈利能力提升，研发投入步入收获期
金融界 · 04-30
生物股份获国海证券买入评级，盈利能力提升，研发投入步入收获期
注意！生物股份将于5月27日召开股东大会
每日经济新闻 · 04-29
注意！生物股份将于5月27日召开股东大会
生物股份4月26日获融资净买入2329万元 环比增加8913.59%
自选股智能写手 · 04-29
生物股份4月26日获融资净买入2329万元 环比增加8913.59%
开源证券发布生物股份研报，公司信息更新报告：业绩韧性十足新品多点开花，动保创新龙头持续成长
每日经济新闻 · 04-28
开源证券发布生物股份研报，公司信息更新报告：业绩韧性十足新品多点开花，动保创新龙头持续成长
生物股份(600201)：非口蹄疫产品补强产品矩阵 盈利能力稳步修复
中国国际金融股... · 04-27
生物股份(600201)：非口蹄疫产品补强产品矩阵 盈利能力稳步修复
中国银河给予生物股份推荐评级，24Q1业绩稳健，毛利率呈提升趋势
每日经济新闻 · 04-26
中国银河给予生物股份推荐评级，24Q1业绩稳健，毛利率呈提升趋势
中国银河：给予生物股份买入评级
证券之星 · 04-26
中国银河：给予生物股份买入评级
生物股份2023年营收15.98亿净利2.84亿 董事长张翀宇薪酬156万
挖贝网 · 04-26
生物股份2023年营收15.98亿净利2.84亿 董事长张翀宇薪酬156万
生物股份(600201)3月31日股东户数5.23万户，较上期减少1.89%
证券之星 · 04-26
生物股份(600201)3月31日股东户数5.23万户，较上期减少1.89%
动物保健行业盘中跳水，普莱柯跌4.92%
自选股智能写手 · 04-26
动物保健行业盘中跳水，普莱柯跌4.92%
图解生物股份一季报：第一季度单季净利润同比减1.05%
证券之星 · 04-26
图解生物股份一季报：第一季度单季净利润同比减1.05%
图解生物股份年报：第四季度单季净利润同比减896.08%
证券之星 · 04-26
图解生物股份年报：第四季度单季净利润同比减896.08%
生物股份(600201.SH)发布一季度业绩，净利润1.06亿元 同比减少1.05%
智通财经 · 04-25
生物股份(600201.SH)发布一季度业绩，净利润1.06亿元 同比减少1.05%
生物股份：2023年度净利润约2.84亿元 同比增加34.64%
每日经济新闻 · 04-25
生物股份：2023年度净利润约2.84亿元 同比增加34.64%
加载更多
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司主要从事兽用生物制品的研发、生产与销售，产品种类涵盖猪、禽、反刍和宠物类四大系列100余种动物疫苗。公司获得了“2019中国上市公司金质量奖”、“2019蛋鸡产业替抗突出贡献奖”、“医药工业百强企业”等荣誉奖项。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":9.14,"timestamp":1714460400000,"preClose":8.94,"halted":0,"volume":20475074,"delay":0,"floatShares":1120000000,"shares":1120000000,"eps":0.2522,"marketStatus":"已收盘","marketStatusCode":5,"change":0.2,"latestTime":"04-30 15:00:00","open":8.95,"high":9.18,"low":8.93,"amount":185000000,"amplitude":0.028,"askPrice":9.15,"askSize":2107,"bidPrice":9.14,"bidSize":58,"shortable":0,"etf":0,"ttmEps":0.2522,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":8.94,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":9.83,"lowLimit":8.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1120369226,"pbRate":1.87,"roa":"--","roe":"1.95%","epsLYR":0.26,"committee":-0.249072,"marketValue":10240000000,"floatMarketCap":10240000000,"peRate":36.241077,"changeRate":0.0224,"turnoverRate":0.0183,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-06。"},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2432550928","title":"生物股份获融资买入0.23亿元，近三日累计买入0.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432550928","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432550928?lang=zh_cn&edition=full","pubTime":"2024-05-01 08:24","pubTimestamp":1714523096,"startTime":"0","endTime":"0","summary":"4月30日，沪深两融数据显示，生物股份获融资买入额0.23亿元，居两市第419位，当日融资偿还额0.23亿元，净买入17.57万元。最近三个交易日，26日-30日，生物股份分别获融资买入0.31亿元、0.20亿元、0.23亿元。融券方面，当日融券卖出3.48万股，净买入2.40万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010825478b68203f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010825478b68203f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431312519","title":"东兴证券：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431312519","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431312519?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:05","pubTimestamp":1714475152,"startTime":"0","endTime":"0","summary":"东兴证券股份有限公司程诗月近期对生物股份进行研究并发布了研究报告《经营质量持续提升，新品落地可期》，本报告对生物股份给出买入评级，当前股价为9.14元。23年公司持续聚焦研发创新，研发投入2.30亿元，占营业收入的比重达14.39%，未来五年布局研发管线新苗40多个。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为11.31。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000045899.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431311952","title":"生物股份(600201)：经营质量持续提升 新品落地可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2431311952","media":"东兴证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2431311952?lang=zh_cn&edition=full","pubTime":"2024-04-30 18:37","pubTimestamp":1714473444,"startTime":"0","endTime":"0","summary":"公司经营稳健，营收质量持续提升。24Q1 养殖行情低迷，收入业绩小幅下滑，但毛利率维持上升趋势，现金流同比明显改善，公司经营质量持续提升。持续推进研发创新，新品落地可期。23 年公司持续聚焦研发创新，研发投入2.30 亿元，占营业收入的比重达14.39%，未来五年布局研发管线新苗40 多个。公司盈利预测及投资评级：我们看好公司经营质量持续改善和未来新产品落地带来的持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301837338b65ebef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301837338b65ebef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431365688","title":"生物股份04月30日主力资金流入1114万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2431365688","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431365688?lang=zh_cn&edition=full","pubTime":"2024-04-30 15:17","pubTimestamp":1714461427,"startTime":"0","endTime":"0","summary":"04月30日, 生物股份股价涨2.24%，报收9.14元，成交金额1.85亿元，换手率1.83%，振幅2.80%，量比1.54。生物股份今日主力资金净流入1114万元，连续3日净流入，上一交易日主力净流入1164万元，今日环比减少4.30%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为71.43%，平均涨幅为0.94%。该股近5个交易日下跌0.44%，主力资金累计净流入3650万元；近20日主力资金累计净流出2562万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301517488b652984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301517488b652984&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431509383","title":"生物股份(600201)2023年年报及2024年一季报点评：盈利能力提升，研发投入步入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2431509383","media":"国海证券","top":-1,"share":"https://www.laohu8.com/m/news/2431509383?lang=zh_cn&edition=full","pubTime":"2024-04-30 14:27","pubTimestamp":1714458440,"startTime":"0","endTime":"0","summary":"事件：2024年4月25日， 生物股份 发布2023年年报及2024年一季报：2023年公司实现营业收入15.98亿元，同比增长4.55%，归母净利润2.84亿元，同比增长34.64%，扣非归母净利润2.54亿元，同比增长29.74%。随着非口蹄疫疫苗销量增长，2023年公司毛利率同比提升4.02个百分点，2024Q1毛利率同比提升1.11个百分点。截至2024年4月25日，定增仍处于审核阶段。研发投入步入收获期。1株)均在年内获得新兽药证书。由于公司产品结构改善盈利能力提升，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043014404687c27b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043014404687c27b53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431838869","title":"生物科技概念盘中拉升，泰林生物涨3.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431838869","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431838869?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:56","pubTimestamp":1714442178,"startTime":"0","endTime":"0","summary":"04月30日，生物科技概念盘中拉升，截至09点56分，生物科技概念整体指数上涨0.54%，报803.090点。从个股上来看，该概念的成分股中，泰林生物涨3.70%，万孚生物、瑞普生物、生物股份涨幅居前。从资金上来看，截止发稿，生物科技概念主力净流入为-3678.18万，其中生物股份受到资金热捧，主力净流入283.77万；拉长时间线来看，该板块近20日主力资金净流入-16.54亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009561879254dff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043009561879254dff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431897169","title":"生物股份获国海证券买入评级，盈利能力提升，研发投入步入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2431897169","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431897169?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:14","pubTimestamp":1714407266,"startTime":"0","endTime":"0","summary":"4月29日，生物股份获国海证券买入评级，近一个月生物股份获得4份研报关注。研报认为，随着养殖行业结构优化与产品竞争力提升，及非口蹄疫疫苗销量增长，公司盈利能力显著增强，毛利率提升。此外，公司研发投入成果显现，已有多个疫苗产品进入新兽药注册或效力评价阶段，研发投入正步入收获期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300014318b62cdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300014318b62cdc7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431833881","title":"注意！生物股份将于5月27日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2431833881","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2431833881?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:58","pubTimestamp":1714381080,"startTime":"0","endTime":"0","summary":"生物股份（SH 600201，收盘价：8.94元）4月29日发布公告称，2024年5月27日14点00分，公司将在内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号公司会议室召开2023年年度股东大会。本次股东大会将审议《公司2023年度董事会工作报告》等议案，2024年5月22日收市后登记在册的股东可现场参会投票，或通过交易所投票系统行使表决权。2023年1至12月份，生物股份的营业收入构成为：生物制药占比92.03%，其他行业占比2.34%。截至发稿，生物股份市值为100亿元。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291701308b6135e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291701308b6135e5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431201042","title":"生物股份4月26日获融资净买入2329万元 环比增加8913.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431201042","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431201042?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:00","pubTimestamp":1714356016,"startTime":"0","endTime":"0","summary":"4月26日，生物股份获融资净买入2329万元，环比上一交易日增加8913.59%。其中，融资买入3115万元，融资偿还785万元。融券方面，融券卖出23.82万股，当前融券余量为89.59万股。A股市场共有1594股获融资净买入，生物股份净买入额排名第54。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291001338b5fb5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291001338b5fb5eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430877237","title":"开源证券发布生物股份研报，公司信息更新报告：业绩韧性十足新品多点开花，动保创新龙头持续成长","url":"https://stock-news.laohu8.com/highlight/detail?id=2430877237","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430877237?lang=zh_cn&edition=full","pubTime":"2024-04-28 08:19","pubTimestamp":1714263540,"startTime":"0","endTime":"0","summary":"开源证券04月27日发布研报称，给予生物股份（600201.SH，最新价：8.91元）买入评级。评级理由主要包括：1）非口产品营收占比超50%，新品多点开花步入收获期；2）动保创新龙头精进不止，高研发投入持续成长。风险提示：猪价上涨不及预期，非瘟疫苗研发不及预期，市场竞争加剧。AI点评：生物股份近一个月获得1份券商研报关注。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042808231687b8ce5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042808231687b8ce5c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430760902","title":"生物股份(600201)：非口蹄疫产品补强产品矩阵 盈利能力稳步修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2430760902","media":"中国国际金融股...","top":-1,"share":"https://www.laohu8.com/m/news/2430760902?lang=zh_cn&edition=full","pubTime":"2024-04-27 13:52","pubTimestamp":1714197166,"startTime":"0","endTime":"0","summary":"发展趋势口蹄疫疫苗销售承压，非口蹄疫产品支撑收入增长。从细分品类看：1）口蹄疫疫苗：23 年销量同比-11.5%，有所下降，我们认为主因养殖户防疫需求减少、且口蹄疫疫苗市场竞争较为激烈；2）非口蹄疫疫苗：占比持续提升，包括猪圆环系列、蓝耳、反刍疫苗等，23 年公司圆支二联、猪圆环、牛二联疫苗销量分别同比+109.3%/+24.6%/+22.9%。反刍、非口蹄疫猪疫苗等产品矩阵持续完善，非瘟疫苗潜在增长空间较大。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271352568b59ac39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404271352568b59ac39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430209670","title":"中国银河给予生物股份推荐评级，24Q1业绩稳健，毛利率呈提升趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2430209670","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430209670?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:36","pubTimestamp":1714142192,"startTime":"0","endTime":"0","summary":"中国银河04月25日发布研报称，给予生物股份（600201.SH，最新价：8.91元）推荐评级。评级理由主要包括：1）23年公司收入&盈利增长，24Q1业绩稳健；2）政采毛利率提升显著，猪苗大单品圆环、圆支增速亮眼；3）持续投入研发，全球首个动物mRNA疫苗生产车间通过静态验收。风险提示：下游养殖疫情复发的风险；产品研发不及预期的风险；产品质量。文章来源：每日经济新闻原标题：中国银河给予生物股份推荐评级，24Q1业绩稳健，毛利率呈提升趋势","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262249268b57ae7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262249268b57ae7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430069662","title":"中国银河：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430069662","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430069662?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:31","pubTimestamp":1714141878,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司谢芝优,陆思源近期对生物股份进行研究并发布了研究报告《24Q1业绩稳健，毛利率呈提升趋势》，本报告对生物股份给出买入评级，当前股价为8.91元。 生物股份 核心观点： 事件：公司发布2023年年度报告&2024年一季度报告。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为11.81。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600057375.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430718912","title":"生物股份2023年营收15.98亿净利2.84亿 董事长张翀宇薪酬156万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430718912","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2430718912?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:34","pubTimestamp":1714134897,"startTime":"0","endTime":"0","summary":"挖贝网4月26日，生物股份 近日发布2023年年度报告，报告期内公司实现营业收入1,598,225,460.25元，同比增长4.55%；归属于上市公司股东的净利润283,630,790.16元，同比增长34.64%。报告期内经营活动产生的现金流量净额为414,833,263.67元，归属于上市公司股东的净资产5,366,883,193.66元。公告显示，报告期内董事、监事、高级管理人员报酬合计818.71万元。此预案尚需经公司2023年年度股东大会审议批准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042620364087b3ab7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042620364087b3ab7e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430542240","title":"生物股份(600201)3月31日股东户数5.23万户，较上期减少1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430542240","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430542240?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:04","pubTimestamp":1714122297,"startTime":"0","endTime":"0","summary":"证券之星消息，近日生物股份披露，截至2024年3月31日公司股东户数为5.23万户，较12月31日减少1008.0户，减幅为1.89%。在动物保健行业个股中，生物股份股东户数高于行业平均水平，截至3月31日，动物保健行业平均股东户数为1.85万户。从股价来看，2023年12月31日至2024年3月31日，生物股份区间跌幅为19.22%，在此期间股东户数减少1008.0户，减幅为1.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600038947.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430729871","title":"动物保健行业盘中跳水，普莱柯跌4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430729871","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430729871?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:42","pubTimestamp":1714095745,"startTime":"0","endTime":"0","summary":"04月26日，动物保健行业盘中跳水，截至09点42分，动物保健行业整体指数下跌2.01%，报3831.150点。从个股上来看，该行业的成分股中，普莱柯跌4.92%，生物股份、瑞普生物、绿康生化跌幅居前。从资金上来看，截止发稿，动物保健行业主力净流入为190.54万，其中生物股份受到资金热捧，主力净流入435.26万；拉长时间线来看，该板块近20日主力资金净流入-1.94亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609422587e83ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042609422587e83ea3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430230948","title":"图解生物股份一季报：第一季度单季净利润同比减1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430230948","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430230948?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:11","pubTimestamp":1714068674,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份2024年一季报显示，公司主营收入3.48亿元，同比下降4.42%；归母净利润1.06亿元，同比下降1.05%；扣非净利润9532.47万元，同比下降5.32%；负债率16.54%，投资收益2.37万元，财务费用-1478.61万元，毛利率60.8%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600002987.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430123424","title":"图解生物股份年报：第四季度单季净利润同比减896.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430123424","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430123424?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:48","pubTimestamp":1714063710,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份2023年年报显示，公司主营收入15.98亿元，同比上升4.55%；归母净利润2.84亿元，同比上升34.64%；扣非净利润2.54亿元，同比上升29.74%；其中2023年第四季度，公司单季度主营收入3.79亿元，同比下降9.76%；单季度归母净利润-467.86万元，同比下降896.08%；单季度扣非净利润-1103.6万元，同比上升26.73%；负债率17.72%，投资收益-183.57万元，财务费用-5615.08万元，毛利率59.19%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601011987b00deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042601011987b00deb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430805562","title":"生物股份(600201.SH)发布一季度业绩，净利润1.06亿元 同比减少1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430805562","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430805562?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:04","pubTimestamp":1714057443,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布2024年一季度报告，报告期内公司实现营业收入3.48亿元，同比减少4.42%;归属于上市公司股东的净利润1.06亿元，同比减少1.05%;归属于上市公司股东的扣除非经常性损益的净利润9532.47万元，同比减少5.32%;基本每股收益0.1元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110862.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430233798","title":"生物股份：2023年度净利润约2.84亿元 同比增加34.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430233798","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430233798?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:05","pubTimestamp":1714053925,"startTime":"0","endTime":"0","summary":"生物股份（SH 600201，收盘价：9.11元）4月25日晚间发布年度业绩报告称，2023年营业收入约15.98亿元，同比增加4.55%；归属于上市公司股东的净利润约2.84亿元，同比增加34.64%；基本每股收益0.26元，同比增加36.84%。生物股份的董事长是张翀宇，男，70岁，学历背景为硕士；总裁是张竞，女，41岁，学历背景为硕士。截至发稿，生物股份市值为102亿元。文章来源：每日经济新闻原标题：生物股份：2023年度净利润约2.84亿元，同比增加34.64%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252340218b539815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252340218b539815&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","stockEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.0506},{"period":"3month","weight":0.1215},{"period":"6month","weight":-0.0266},{"period":"1year","weight":-0.1452},{"period":"ytd","weight":-0.1513}],"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","perCapita":"21437股","boardName":"医药制造业","registeredCapital":"112036万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 金宇生物技术股份有限公司主要从事兽用生物制品的研发、生产与销售，产品种类涵盖猪、禽、反刍和宠物类四大系列100余种动物疫苗。公司获得了“2019中国上市公司金质量奖”、“2019蛋鸡产业替抗突出贡献奖”、“医药工业百强企业”等荣誉奖项。","serverTime":1714768851896,"listedPrice":6.83,"stockholders":"52262人(较上一季度减少1.89%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}